vimarsana.com

Latest Breaking News On - Solid biosciences company profile - Page 1 : vimarsana.com

Solid Biosciences Inc (NASDAQ:SLDB) Given Consensus Rating of Buy by Brokerages

Shares of Solid Biosciences Inc. (NASDAQ:SLDB – Get Free Report) have received a consensus rating of “Buy” from the six research firms that are covering the company, Marketbeat reports. Six analysts have rated the stock with a buy recommendation. The average 1 year price target among brokers that have updated their coverage on the stock […]

Insider Selling: Solid Biosciences Inc (NASDAQ:SLDB) CFO Sells 3,935 Shares of Stock

Solid Biosciences Inc. (NASDAQ:SLDB – Get Free Report) CFO Kevin Tan sold 3,935 shares of the company’s stock in a transaction on Tuesday, January 9th. The stock was sold at an average price of $8.20, for a total value of $32,267.00. Following the sale, the chief financial officer now directly owns 9,308 shares in the […]

Jessie Hanrahan Sells 4,879 Shares of Solid Biosciences Inc (NASDAQ:SLDB) Stock

Solid Biosciences Inc. (NASDAQ:SLDB – Get Free Report) insider Jessie Hanrahan sold 4,879 shares of Solid Biosciences stock in a transaction that occurred on Monday, December 4th. The stock was sold at an average price of $2.78, for a total value of $13,563.62. Following the transaction, the insider now owns 6,983 shares of the company’s […]

Q3 2023 EPS Estimates for Solid Biosciences Inc Lifted by Analyst (NASDAQ:SLDB)

Solid Biosciences Inc. (NASDAQ:SLDB – Free Report) – Equities research analysts at Leerink Partnrs raised their Q3 2023 earnings per share (EPS) estimates for Solid Biosciences in a research note issued to investors on Wednesday, August 16th. Leerink Partnrs analyst J. Schwartz now expects that the company will post earnings of ($1.05) per share for […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.